会前研讨会 (上午) & 主会议 第1天 (下午)
Pre-Conference Workshops (am) & Main Conference Day 1 Plenary (pm)
8:00am - 9:00am60分钟
Registration and Coffee
报到・咖啡时光
报到・咖啡时光
Optional Pre-Conference Workshops
可选选项:会前研讨会
可选选项:会前研讨会
9:00am - 9:10am10分钟
Workshop #1: Oligonucleotide Manufacturing Insights At Large Scale
研讨会#1:大规模寡核苷酸生产分析
研讨会#1:大规模寡核苷酸生产分析
Workshop Moderator's Opening Remarks: Workshop #1
研讨会主持人致辞:研讨会#1
研讨会主持人致辞:研讨会#1
- Thomas Rupp - Managing Director, Axolabs Berlin GmbH
9:00am - 9:10am10分钟
Workshop #2: Innovations and Challenges in Peptide Manufacturing
研讨会#2:胜肽制造的创新与挑战
研讨会#2:胜肽制造的创新与挑战
Workshop Co-Moderators' Opening Remarks: Workshop #2
研讨会主持人致辞:研讨会#2
研讨会主持人致辞:研讨会#2
- Bruce Morimoto, PhD - Drug Development Advisor, Independent Advisor
- Robert Hagopian - Director Business Development, PolyPeptide Group
9:10am - 9:55am45分钟
Workshop #1: Oligonucleotide Manufacturing Insights At Large Scale
研讨会#1:大规模寡核苷酸生产分析
研讨会#1:大规模寡核苷酸生产分析
Large Scale Manufacturing: Challenges and Solutions
大规模制造:课题与解决方案
大规模制造:课题与解决方案
- Chris Oswald - Founder, Owner, and Principal Consultant, Coswald Consulting LLC
9:10am - 9:50am40分钟
Workshop #2: Innovations and Challenges in Peptide Manufacturing
研讨会#2:胜肽制造的创新与挑战
研讨会#2:胜肽制造的创新与挑战
Challenges of Raw Material Acquisition for Peptide Synthesis
采购胜肽合成原料的课题
采购胜肽合成原料的课题
- Robert Hagopian - Director Business Development, PolyPeptide Group
9:50am - 10:35am45分钟
Workshop #2: Innovations and Challenges in Peptide Manufacturing
研讨会#2:胜肽制造的创新与挑战
研讨会#2:胜肽制造的创新与挑战
Sustainability Challenge in Cyclic Peptide Synthesis: The Power of Crystallization and CSPS
环肽合成上的可持续性课题:结晶和 CSPS 的力量
环肽合成上的可持续性课题:结晶和 CSPS 的力量
- Hiroshi Iwamura, PhD - Deputy Head of API Process Development Department, Chugai Pharmaceutical Co., Ltd.
9:55am - 10:40am45分钟
Workshop #1: Oligonucleotide Manufacturing Insights At Large Scale
研讨会#1:大规模寡核苷酸生产分析
研讨会#1:大规模寡核苷酸生产分析
Designing a Facility: Challenges and Solutions
设备设计:课题与解决方案
设备设计:课题与解决方案
- Thomas Rupp - Managing Director, Axolabs Berlin GmbH
10:35am - 11:10am35分钟
Workshop #2: Innovations and Challenges in Peptide Manufacturing
研讨会#2:胜肽制造的创新与挑战
研讨会#2:胜肽制造的创新与挑战
Networking Refreshment Break
互动交流休息时间
互动交流休息时间
10:40am - 11:15am35分钟
Workshop #1: Oligonucleotide Manufacturing Insights At Large Scale
研讨会#1:大规模寡核苷酸生产分析
研讨会#1:大规模寡核苷酸生产分析
Networking Refreshment Break
互动交流休息时间
互动交流休息时间
11:10am - 11:50am40分钟
Workshop #2: Innovations and Challenges in Peptide Manufacturing
研讨会#2:胜肽制造的创新与挑战
研讨会#2:胜肽制造的创新与挑战
Crystallisation as a Purification and IP-extension) Strategy in Peptide Manufacturing
作为纯化方式的结晶化与胜肽制造上的 IP 扩展策略
作为纯化方式的结晶化与胜肽制造上的 IP 扩展策略
- Alaric Desmarchelier, PhD - Business Development Manager - Peptides, Almac Group
11:15am - 12:00pm45分钟
Workshop #1: Oligonucleotide Manufacturing Insights At Large Scale
研讨会#1:大规模寡核苷酸生产分析
研讨会#1:大规模寡核苷酸生产分析
Critical Quality Attributes (CQA): How to Maintain During Upscaling
CQA (重要品质属性):扩大规模期间的维持方法
CQA (重要品质属性):扩大规模期间的维持方法
- Hagen Cramer, PhD - Chief Technology Officer, QurAlis
11:50am - 12:30pm40分钟
Workshop #2: Innovations and Challenges in Peptide Manufacturing
研讨会#2:胜肽制造的创新与挑战
研讨会#2:胜肽制造的创新与挑战
Late Breaking Presentation
发表最新成果
发表最新成果
12:00pm - 12:30pm30分钟
Workshop #1: Oligonucleotide Manufacturing Insights At Large Scale
研讨会#1:大规模寡核苷酸生产分析
研讨会#1:大规模寡核苷酸生产分析
Panel Discussion and Q&A with Workshop Speakers
与研讨会演讲嘉宾进行小组讨论和问与答
与研讨会演讲嘉宾进行小组讨论和问与答
- Thomas Rupp - Managing Director, Axolabs Berlin GmbH
- Chris Oswald - Founder, Owner, and Principal Consultant, Coswald Consulting LLC
- Hagen Cramer, PhD - Chief Technology Officer, QurAlis
12:30pm - 1:45pm75分钟
Close of Workshop and Luncheon for Morning Workshop Attendees Only
研讨会闭幕、午餐会(仅限上午研讨会参与者参加)
研讨会闭幕、午餐会(仅限上午研讨会参与者参加)
1:45pm - 1:50pm5分钟
Main Conference Plenary Keynote Session
主会议:主题讲演单元
主会议:主题讲演单元
Chairperson’s Remarks: Keynote Day 1
主席致辞:主题讲演(第1天)
主席致辞:主题讲演(第1天)
- Yogesh Sanghvi, PhD - President, Rasayan Inc.
1:50pm - 2:20pm30分钟
Main Conference Plenary Keynote Session
主会议:主题讲演单元
主会议:主题讲演单元
RaPID Display and Selection of Pseudo-natural Products
RaPID显示方法及伪天然产物
RaPID显示方法及伪天然产物
- Hiroaki Suga, PhD - Professor of Chemistry, School of Science, University of Tokyo, Japan
2:20pm - 2:50pm30分钟
Main Conference Plenary Keynote Session
主会议:主题讲演单元
主会议:主题讲演单元
Biological Research with Thiomorpholino Oligonucleotides (TMOs)
TMO (Thiomorpholino Oligonucleotides) 相关之生物学研究
TMO (Thiomorpholino Oligonucleotides) 相关之生物学研究
- Marvin Caruthers, PhD - Distinguished Professor, Biochemistry, University of Colorado
2:50pm - 3:20pm30分钟
Main Conference Plenary Keynote Session
主会议:主题讲演单元
主会议:主题讲演单元
RNA Therapeutics Modalities and Targeted Delivery Approaches for Developing Transformational Medicines for Patients
为患者开发创新药物所用的 RNA 治疗方式和标靶递送方法
为患者开发创新药物所用的 RNA 治疗方式和标靶递送方法
- Tamar Grossman, PhD - VP, Global Head of RNA, Gene Therapy and Delivery, Johnson & Johnson Innovative Medicine
3:20pm - 4:00pm40分钟
Main Conference Plenary Keynote Session
主会议:主题讲演单元
主会议:主题讲演单元
Networking Refreshment Break
互动交流休息时间
互动交流休息时间
4:00pm - 4:30pm30分钟
Main Conference Plenary Keynote Session
主会议:主题讲演单元
主会议:主题讲演单元
Cell Penetrating Properties of Cyclotides and Their Applications for Intracellular Targets
环肽的细胞渗透特性及其在细胞内靶标的应用
环肽的细胞渗透特性及其在细胞内靶标的应用
- David Craik, PhD - Professor of Biomolecular Structure, University of Queensland
4:30pm - 5:00pm30分钟
Main Conference Plenary Keynote Session
主会议:主题讲演单元
主会议:主题讲演单元
State of the Art siRNA and Future Perspectives
尖端siRNA及未来展望
尖端siRNA及未来展望
- Tomaz Einfalt, PhD - Principal Investigator II xRNA, Novartis Institutes for BioMedical Research
5:00pm - 5:30pm30分钟
Main Conference Plenary Keynote Session
主会议:主题讲演单元
主会议:主题讲演单元
Therapeutic Genome Editing with ePsCas9 Using Lipid Nanoparticles
利用脂质奈米粒子透过 ePsCas9 进行治疗性基因组编辑
利用脂质奈米粒子透过 ePsCas9 进行治疗性基因组编辑
- Grzegorz Sienski, PhD - Director and Project Leader, AstraZeneca
5:30pm - 5:35pm5分钟
Close of Day One
第1天结束
第1天结束
* 活动内容有可能不事先告知作更动及调整。